Sathyapalan, Thozhukat <br/><br/>
Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Nov 2012 
 - 3951-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2012-2279  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Atorvastatin<br/>Double-Blind Method<br/>Female<br/>Heptanoic Acids--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hypoglycemic Agents--pharmacology<br/>Insulin Resistance<br/>Malondialdehyde--blood<br/>Metformin--pharmacology<br/>Oxidative Stress--drug effects<br/>Polycystic Ovary Syndrome--blood<br/>Pyrroles--pharmacology<br/>Treatment Outcome